Selective PDE 2 inhibitors as pharmaceuticals for improving perception

US7022709B2 · kind B2 · utility

Inventors

• Frank-Gerhard Boss · Wuppertal, DE
• Martin Hendrix · Tarrytown, US
• Gerhard Konig · Düsseldorf, DE
• Ulrich Niewohner · Wermelskirchen, DE
• Karl-Heinz Schlemmer · Wuppertal, DE
• Rudy Schreiber · Menlo Park, US
• Franz-Josef van der Staay · Dronten, NL
• Dagmar Schauss · Wuppertal, DE

Key dates

• Filing date: Jul 23, 2001
• Grant date: Apr 4, 2006
• Expiry date: Jul 23, 2021

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to the use of selective phosphodiesterase 2 (PDE 2) inhibitors for producing pharmaceuticals for improving perception, concentration, learning and/or memory.